| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |